These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 978070)

  • 41. Clinical and histological characteristics of renal AA amyloidosis: a retrospective study of 68 cases with a special interest to amyloid-associated inflammatory response.
    Verine J; Mourad N; Desseaux K; Vanhille P; Noël LH; Beaufils H; Grateau G; Janin A; Droz D
    Hum Pathol; 2007 Dec; 38(12):1798-809. PubMed ID: 17714761
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Renal amyloidosis: clinical study in 29 patients].
    Castilla Jiménez J; Montes Delgado R; Quereda Rodriguez-Navarro C; Marcen Letosa R; Rodriguez Algarra G; Pereira Palomo P; Mendoza Llera M; Martínez Martin A; Mateos Aguilar J
    Rev Clin Esp; 1977 Nov; 147(4):349-54. PubMed ID: 601292
    [No Abstract]   [Full Text] [Related]  

  • 43. [Deposits of amyloid substance in basocellular epithelioma. Histochemical, immunologic and ultrastructural study of 50 cases].
    Aloi FG; Depaoli MA; Giovannini E; Mascoli I; Zina AM
    G Ital Dermatol Venereol; 1982; 117(1):51-5. PubMed ID: 6195099
    [No Abstract]   [Full Text] [Related]  

  • 44. [Amyloidoses].
    Wuchter J; Schirmeister J
    Med Klin; 1978 Jun; 73(25):933-40. PubMed ID: 351359
    [No Abstract]   [Full Text] [Related]  

  • 45. [Amyloidosis (apropos of 5 cases)].
    Ramos González I; Lasierra Cirujeda J; Vilades Juan E; Sánchez Casajús A
    Rev Clin Esp; 1978 Jan; 148(1):41-6. PubMed ID: 635251
    [No Abstract]   [Full Text] [Related]  

  • 46. Eosinophilia and amyloidosis.
    Howlett SA; Cerda JJ
    South Med J; 1976 Apr; 69(4):400, 423. PubMed ID: 1265493
    [No Abstract]   [Full Text] [Related]  

  • 47. Deposition of complement C1q in primary localized cutaneous amyloidosis.
    Danno K; Imamura S
    Br J Dermatol; 1982 Feb; 106(2):129-33. PubMed ID: 7037040
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immunofluorescence studies on complement components in lichen amyloidosus.
    Sudo S; Igarashi R; Morohashi M
    Acta Derm Venereol; 1982; 62(6):516-9. PubMed ID: 6187159
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immunoglobulins and complement C' 3 in lichen amyloidosus. Immunofluorescent study.
    Stringa SG; Bianchi C; Casala A; Bianchi O
    Arch Dermatol; 1972 Apr; 105(4):541-3. PubMed ID: 4111676
    [No Abstract]   [Full Text] [Related]  

  • 50. Renal biopsy findings in familial amyloidosis with corneal lattice dystrophy. An immuno-histochemical, light-microscopical and electron-microscopical study.
    Meretoja J; Jokinen EJ; Collan Y; Lähdevirta J
    Acta Pathol Microbiol Scand Suppl; 1972; 233():228-38. PubMed ID: 4561509
    [No Abstract]   [Full Text] [Related]  

  • 51. [Amyloidosis localized in the seminal vesicles: clinico-pathological review of 8 cases diagnosed in surgical specimens].
    Caballero Martínez MC; Gómez Dorronsoro ML; Cuesta Alcalá JA; Amat Villegas I; Beloqui Pérez R; Martínez Peñuela JM; Monzón Muñoz FJ
    Arch Esp Urol; 2003 May; 56(4):431-4. PubMed ID: 12830618
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Primary cutaneous amyloidosis : clinical, histological, histochemical immunofluorescent and peroxidase studies of 134 cases in 2 years.
    Piamphongsant T; Sittapairoachana D
    J Med Assoc Thai; 1976 Oct; 59(10):435-9. PubMed ID: 978070
    [No Abstract]   [Full Text] [Related]  

  • 53.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 3.